Skip to content
Menu

Stevanato Group S.p.A. STVN

Full chart Compare
Set alert

Price alert · STVN

All alert types
15.65 USD -0.28 (-1.76%)

Regular-session close

15.65 0.00 0.00%

After hours · Nov 20, 4:00 PM ET

15.35 Day range 16.15
13.21 52-week range 23.43
YTD
-22.22%
1 year
-26.04%

5D +0.03 (+0.19%)

15.5016MonTueWedThuFri15.65
Market cap
4.27B
Revenue (ttm)
1.25B
Profit margin
11.25%
EPS (ttm)
0.59
Shares out
49.83M
P/E ratio
26.53
Forward P/E
21.70
Dividend
0.06 (0.39%)
Ex-dividend date
Jun 11, 2026
YTD return
-22.22%
1-year return
-26.04%
Volume
752.32K
Avg volume
649.01K
Open
15.90
Previous close
15.93
Day's range
15.35 – 16.15
52-week range
13.21 – 23.43
Beta
0.80
Analysts
Buy
Price target
19.46 (+24.3%)
Earnings date
Mar 3, 2027
50-day average
18.75

Key statistics

200-day average
17.92
Enterprise value
4.71B
PEG ratio
1.90
Price / sales
3.44
Price / book
2.40
Payout ratio
10.59%
Revenue growth
7.60%
Free cash flow
-65.24M
Total cash
116.02M
Total debt
471.43M
Return on equity
9.26%
Short % of float
1.81%

Fundamental scorecard

14 of 25 checks passed on STVN’s reported financials

ValueGrowthProfitabilityHealthDividend

14of 25 checks passed

  • Value 3 of 5
  • Growth 4 of 5
  • Profitability 2 of 5
  • Financial health 5 of 5
  • Dividend No data

Statements to Sep 30, 2026.

Financials — quick view

All financials
STVN Revenue — quarterly 326.06M
STVN Net income — quarterly 41.84M
STVN EPS — quarterly 0.15

Earnings

STVN recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Mar 3, 2027Dec 30, 20260.22———
Nov 3, 2026Sep 30, 20260.17750.180.00+1.41%
Aug 4, 2026Jun 30, 20260.14480.16+0.02+10.50%
May 7, 2026Mar 31, 20260.120.13+0.01+8.33%
Mar 4, 2026Dec 31, 20250.200.21+0.01+5.00%
Nov 6, 2025Sep 30, 20250.140.16+0.02+14.29%

Upgrades / downgrades

STVN analyst upgrades and downgrades
DateFirmActionFromTo
Nov 4, 2026William BlairdownOutperformMarket Perform
Nov 4, 2026UBSmainNeutralNeutral
Nov 4, 2026CitigroupmainBuyBuy
Sep 9, 2026UBSmainNeutralNeutral
Jun 16, 2026TD Coweninit—Buy
Mar 6, 2026Morgan StanleymainEqual-WeightEqual-Weight

About Stevanato Group S.p.A.

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
Italy

News

Your note

Sign in to keep a note on STVN — it syncs with the Stock Master app.

Insider holders

STVN insider holders
InsiderRelationLatest transactionDateShares held
BALACHANDRAN MADHAVENDirectorSaleJun 14, 202669,458
DAL LAGO MARCOChief Financial OfficerSaleAug 6, 202681,144
FEDERICI WILLIAM JDirectorSaleJun 14, 202658,580
FLYNN KAREN ADirectorSaleJun 14, 20265,757
LIN SUE-JEANDirectorStock Award(Grant)Jun 11, 20266,975
MAGISTRETTI ELISABETTADirectorSaleAug 6, 20262,930

Institution ownership

STVN institution ownership
Holder% heldSharesValueReported
Conestoga Capital Advisors, LLC1.85%5,596,51587.92MSep 29, 2026
Neuberger Berman Group, LLC1.85%5,605,03388.06MSep 29, 2026
Times Square Capital Management, LLC1.07%3,252,89951.10MSep 29, 2026
BAMCO Inc.0.97%2,927,89646.00MSep 29, 2026
Van Berkom & Associates Inc.0.94%2,858,32344.90MSep 29, 2026
Artisan Partners Limited Partnership0.85%2,565,89040.31MSep 29, 2026

Fund ownership

STVN fund ownership
Holder% heldSharesValueReported
Conestoga Funds-Conestoga Small Cap Fund1.15%3,484,75154.75MJun 29, 2026
NEUBERGER BERMAN EQUITY FUNDS-Neuberger Genesis Fund1.00%3,041,14147.78MSep 29, 2026
BARON INVESTMENT Fd.S TRT -BARON DISCOVERY Fd.0.56%1,681,42926.42MJun 29, 2026
American Century Mutual Funds, Inc.-Small Cap Growth Fund0.32%977,76515.36MSep 29, 2026
Artisan Partners Funds Inc.-Artisan Small Cap Fund0.28%837,77313.16MJun 29, 2026
AMG Funds-AMG TimesSquare Mid Cap Growth Fund0.22%653,13710.26MJun 29, 2026